Vimarsana
Biggest News Aggregation in the World

Page 2 - 86845910 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 86845910. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 86845910 Today - Breaking & Trending Today

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Purchased by Campbell Newman Asset Management Inc. - Vimarsana News

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Purchased by Campbell Newman Asset Management Inc.

Campbell Newman Asset Management Inc. raised its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 63.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,355 shares of the specialty pharmaceutical company’s stock after purchasing an additional 16,476 shares during the quarter. Campbell […]

Source: wkrb13.com
Legato Capital Management LLC Has $592,000 Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Vimarsana News

Legato Capital Management LLC Has $592,000 Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Legato Capital Management LLC decreased its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,472 shares of the specialty pharmaceutical company’s stock after selling 837 shares during […]

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Buy at StockNews.com - Vimarsana News

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Separately, Piper Sandler raised their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on Thursday, November 9th. […]

Source: wkrb13.com
Supernus Pharmaceuticals (NASDAQ:SUPN) Raised to Buy at StockNews.com - Vimarsana News

Supernus Pharmaceuticals (NASDAQ:SUPN) Raised to Buy at StockNews.com

StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a research report released on Saturday. Separately, Piper Sandler increased their target price on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the stock an overweight rating in a report on Thursday, November 9th. […]

Retirement Planning Co of New England Inc. Lowers Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Vimarsana News

Retirement Planning Co of New England Inc. Lowers Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Retirement Planning Co of New England Inc. reduced its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 8.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,952 shares of the specialty pharmaceutical company’s stock after selling 2,625 shares during the […]

Source: wkrb13.com